# Evaluation of Bioavailability of Diclofenac Dermal Products

> **NCT03145259** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 12 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** Diclofenac Epolamine Patch
- **DRUG:** diclofenac sodium solution

## Key facts

- **NCT ID:** NCT03145259
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-19
- **Primary completion:** 2019-08-29
- **Final completion:** 2020-05-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03145259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03145259, "Evaluation of Bioavailability of Diclofenac Dermal Products". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03145259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*